Back to

Dr Shiying Zheng

Conjoint Senior Lecturer
  • Doctor of Philosophy (Medicine), University of NSW, Sydney, Australia (2016-2023)
  • Fellow, the Royal College of Pathologist of Australasia (2017-current)
  • Fellow, the Royal Australasian College of Physician (2017-current)
  • MBBS, BSc (Medicine), University of NSW, Sydney, Australia (2002 – 2007)
Medicine & Health
School of Clinical Medicine

Dr. Silvia Zheng (MBBS, BSc (Med), PhD, FRACP, FRCPA) is a clinical haematologist at St. George Hospital, and conjoint senior lecturer at UNSW, Australia. She completed her PhD at University of New South Wales, on “Antibody-mediated thrombocytopenias: mechanisms and potential treatments”, under the supervision of Professor Beng Chong in 2023. Her research focuses on immune thrombocytopenia as well as diseases and treatments in the field of thrombosis and haemostasis. She currently serves as the Early Career co-chair for the Scientific and Standardization Subcommittee on Platelet Immunology, ISTH.
Phone
+61291133438
  • Journal articles | 2024
    Zheng SS; Perdomo JS, 2024, 'Desialylation and Apoptosis in Immune Thrombocytopenia: Implications for Pathogenesis and Treatment', Current Issues in Molecular Biology, 46, pp. 11942 - 11956, http://dx.doi.org/10.3390/cimb46110709
    Journal articles | 2023
    Verissimo V; Carter T; Wright H; Robertson J; Osborn M; Bradbeer P; Sabesan V; Saxon B; Barbaro P; Crighton G; Chamberlain J; Zheng S; Freeman K, 2023, 'Australian and New Zealand consensus guideline for paediatric newly diagnosed immune thrombocytopaenia endorsed by Australian New Zealand Children's Haematology and Oncology Group.', J Paediatr Child Health, 59, pp. 711 - 717, http://dx.doi.org/10.1111/jpc.16395
    Journal articles | 2022
    Leung HHL; Perdomo J; Ahmadi Z; Zheng SS; Rashid FN; Enjeti A; Ting SB; Chong JJH; Chong BH, 2022, 'NETosis and thrombosis in vaccine-induced immune thrombotic thrombocytopenia', Nature Communications, 13, http://dx.doi.org/10.1038/s41467-022-32946-1
    Journal articles | 2022
    Zheng SS; Ahmadi Z; Leung HHL; Wong R; Yan F; Perdomo JS; Chong BH, 2022, 'Antiplatelet antibody predicts platelet desialylation and apoptosis in immune thrombocytopenia', Haematologica, 107, pp. 2195 - 2205, http://dx.doi.org/10.3324/haematol.2021.279751
    Journal articles | 2021
    Zheng SS; Perdomo JS; Ahmadi Z; Chong BH, 2021, 'Indirect detection of anti-platelet antibodies in immune thrombocytopenia', Pathology, 53, pp. 759 - 762, http://dx.doi.org/10.1016/j.pathol.2020.12.006
    Journal articles | 2020
    Li L; Yi C; Xia WJ; Huang B; Chen S; Zhong J; Fang X; Yang L; Xin H; Zheng SS; Chong BH; Fu Y; Chen C; Yang M, 2020, 'c-Mpl and TPO expression in the human central nervous system neurons inhibits neuronal apoptosis', Aging, 12, pp. 7397 - 7410, http://dx.doi.org/10.18632/AGING.103086
    Journal articles | 2020
    Zheng SS; Perdomo JS; Leung HHL; Yan F; Chong BH, 2020, 'Acquired Glanzmann thrombasthenia associated with platelet desialylation', Journal of Thrombosis and Haemostasis, 18, pp. 714 - 721, http://dx.doi.org/10.1111/jth.14722
    Journal articles | 2016
    Kidson-Gerber G; Zheng S, 2016, 'Iron deficiency in pregnancy What you need to know', Medicine Today, 17, pp. 41 - 46
    Journal articles | 2016
    Zheng S; Just S; Brighton T, 2016, 'Prekallikrein deficiency', Pathology, 48, pp. 634 - 637, http://dx.doi.org/10.1016/j.pathol.2016.07.005
    Journal articles | 2016
    Zheng SS; Brighton T, 2016, 'The ABC of ET – From abnormal bleeding to clotting, an unusual presentation of essential thrombocythaemia', Pathology, 48, pp. S36 - S36, http://dx.doi.org/10.1016/j.pathol.2015.12.088
    Journal articles | 2016
    Zheng SS; Chong JJH; Chong BH, 2016, 'Pharmacodynamics, pharmacokinetics and clinical efficacy of apixaban in the treatment of thrombosis', Expert Opinion on Drug Metabolism and Toxicology, 12, pp. 575 - 580, http://dx.doi.org/10.1517/17425255.2016.1164692
    Journal articles | 2015
    Zheng S; Chan H; Epstein RJ; Joseph JE, 2015, 'Resolution of paraneoplastic immune thrombocytopenia following everolimus treatment for metastatic renal cell carcinoma', Internal Medicine Journal, 45, pp. 666 - 669, http://dx.doi.org/10.1111/imj.12779

  • 2025 ISTH Training Fellowship
  • 2024 National Health and Medical Research Council (NHMRC) Ideas Grant (Chief Investigator D)
  • 2022 UNSW High Degree by Research Completion Scholarship
  • 2021 THANZ Travel Grant
  • 2019 THANZ Travel Grant
  • 2018-2019 NSW Health PhD Scholarship, NSW Ministry of Health

  • 2023 Dean of Graduate Research Award for Outstanding PhD Thesis
  • 2022 Australian & New Zealand Society of Blood Transfusion (ANZSBT) Best Poster Prize
  • 2021 THANZ Medal Runner Up
  • 2019 THANZ Medal Runner Up
  • 2019 Early Career Award, ISTH
  • 2018 Poster Award, 10th Congress of the Asian-Pacific Society of Thrombosis and Hemostasis

 

  • Postdoctoral Fellow (2025), Hollenhorst Laboratory, Harvard Medical Institute
  • Immuno-thromboses that kill and maim: Pathogenesis and novel treatments (2024- Present)
    • Role: Chief Investigator D
    • Institution: University of New South Wales, Sydney 
  • Antibody-mediated thrombocytopenia: Novel Mechanisms and Potential Treatment (2016-2023)
    • Role: PhD Candidate
    • Supervisor: Professor Beng Chong
    • Institution: University of New South Wales, Sydney